Reportlinker Adds Chugai Pharmaceutical Co Ltd PharmaVitae Profile

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Immucor, Inc. - Strategic SWOT Analysis Review

Immucor, Inc. - Strategic SWOT Analysis Review

  • $ 125
  • Company report
  • by Global Data
  • September 2014
  • 33 pages

Immucor, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services. ...

Industries: In Vitro Diagnostic | Countries: Canada, United States, Spain, Portugal, Italy, France, Germany, Belgium, Japan, India, Georgia

Chiral Chromatography Column Market by type (Empty, Pre-packed, Analytical, Preparative), Material (Metal, Glass, Plastic), & by Application [GC, LC (HPLC, UHPLC, Flash Chromatoraphy, UFLC), TLC,SFC] - Forecast to 2018

Chiral Chromatography Column Market by type (Empty, Pre-packed, Analytical, Preparative), Material (Metal, Glass, Plastic), & by Application [GC, LC (HPLC, UHPLC, Flash Chromatoraphy, UFLC), TLC,SFC] - Forecast to 2018

  • $ 4 650
  • Industry report
  • by MarketsandMarkets
  • September 2014
  • 122 pages

Over the years, the chiral chromatography columns market has witnessed various technological advancements that have led to an increase in the application areas of chiral chromatography columns. For instance, chiral chromatography columns are widely used in academic research laboratories and a numbe ...

Industries: In Vitro Diagnostic | Countries: World, India, China, Japan, Europe, Canada, Spain, Italy, France, Germany, North America, Asia, United States

Horiba, Ltd. (6856) - Product Pipeline Analysis, 2014 Update

Horiba, Ltd. (6856) - Product Pipeline Analysis, 2014 Update

  • $ 750
  • Company report
  • by Global Data
  • September 2014
  • 22 pages

Summary HORIBA, Ltd. (Horiba) is a medical device company. The company provides an array of instruments and systems for applications ranging from in-vitro medical diagnostics, semiconductor manufacturing and metrology, automotive research and development, process and environmental monitoring, to a broad ...

Industries: In Vitro Diagnostic | Countries: India, Japan

Future Horizons and Growth Strategies in the Global Hemostasis Diagnostic Testing Market 2014: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the Global Hemostasis Diagnostic Testing Market 2014: Supplier Shares and Country Forecasts

  • $ 21 100
  • Industry report
  • by Venture Planning Group
  • August 2014
  • 650 pages

Complete report $32,500.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Summary This comprehensive seven-country report contains 650 pages, 150 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in ...

Industries: In Vitro Diagnostic | Countries: Spain, Germany, United States, Italy, France, Japan, World, Europe

Future Horizons and Growth Strategies in the Japanese Hemostasis Diagnostic Market 2014: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the Japanese Hemostasis Diagnostic Market 2014: Supplier Shares and Country Forecasts

  • $ 4 800
  • Industry report
  • by Venture Planning Group
  • August 2014
  • 402 pages

Complete report $7,400.  DataPack (test volumes, sales forecasts, supplier shares) $4,800. Summary This comprehensive report contains 402 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the Japanese coagulation ...

Industries: In Vitro Diagnostic | Countries: Japan

Future Horizons and Growth Strategies in the Japanese Hospital Hemostasis Diagnostic Testing Market 2014: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the Japanese Hospital Hemostasis Diagnostic Testing Market 2014: Supplier Shares and Country Forecasts

  • $ 3 200
  • Industry report
  • by Venture Planning Group
  • August 2014
  • 392 pages

This new report from Venture Planning Group contains 392 pages, 28 tables, and presents a comprehensive analysis of the Japanese hospital hemostasis diagnostic testing market, including:  Major issues pertaining to the Japanese coagulation laboratory practice, as well as key economic, regulatory, demographic, ...

Industries: In Vitro Diagnostic | Countries: Japan

Future Horizons and Growth Strategies in the Japanese Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the Japanese Microbiology Testing Market 2014: Supplier Shares and Country Forecasts

  • $ 5 700
  • Industry report
  • by Venture Planning Group
  • August 2014
  • 976 pages

Complete report $8,800.  DataPack (test volumes, sales forecasts, supplier shares) $5,700. “2014 Strategies for the Japanese Microbiology Testing Market” is a new strategic analysis of major business opportunities emerging in the infectious disease testing market during the next five years.  The ...

Industries: In Vitro Diagnostic | Countries: Japan

Future Horizons and Growth Strategies in the Global Nucleic Acid Testing Market 2014: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the Global Nucleic Acid Testing Market 2014: Supplier Shares and Country Forecasts

  • $ 20 900
  • Industry report
  • by Venture Planning Group
  • August 2014
  • 1050 pages

This unique seven-country report , 1,050-page report is designed to help current suppliers and potential market entrants identify and evaluate major business opportunities emerging in the NAT market during this decade.  Highlights - Business and technological trends in seven major markets - Five- and ...

Industries: In Vitro Diagnostic | Countries: World, United States, Japan

Future Horizons and Growth Strategies in the Japanese Nucleic Acid Testing Market 2014: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the Japanese Nucleic Acid Testing Market 2014: Supplier Shares and Country Forecasts

  • $ 5 500
  • Industry report
  • by Venture Planning Group
  • August 2014
  • 850 pages

Highlights Comprehensive 850-page market segmentation analysis of the Japanese NAT market. Major issues pertaining to the Japanese NAT laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years. An ...

Industries: In Vitro Diagnostic | Countries: Japan

Future Horizons and Growth Strategies in the Global Transfusion Diagnostic Testing Market 2014: Supplier Shares and Country Forecasts

Future Horizons and Growth Strategies in the Global Transfusion Diagnostic Testing Market 2014: Supplier Shares and Country Forecasts

  • $ 19 500
  • Industry report
  • by Venture Planning Group
  • August 2014

Complete report $32,500.  DataPack (test volumes, sales forecasts, supplier shares) $19,500. This comprehensive seven-country report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global transfusion diagnostic market during the ...

Industries: In Vitro Diagnostic | Countries: United States, Spain, France, Germany, Japan, Italy, World, Europe

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.